Bluejay Diagnostics, Inc. (BJDX) NASDAQ

1.37

+0.005(+0.36%)

Updated at August 28 04:00PM

Currency In USD

Bluejay Diagnostics, Inc.

Address

360 Massachusetts Avenue

Acton, MA 01720

United States of America

Phone

844 327 7078

Sector

Healthcare

Industry

Medical - Devices

Employees

7

First IPO Date

November 10, 2021

Key Executives

NameTitlePayYear Born
Mr. Indranil DeyPrincipal Financial, Accounting & Executive Officer, President, Chief Executive Officer and Director290,8871964
Dr. Jason CookChief Technology Officer251,0681983
Dr. Mark W. Feinberg M.D.Chief Medical Advisor0N/A
Mr. Mark W. Feinberg M.D., Ph.D.Chief Medical Advisor0N/A
Mr. Kevin VanceChief Commercial Officer01958

Description

Bluejay Diagnostics, Inc., a diagnostic company, develops and markets patient products for triage, diagnosis, and monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony Fluorescence Immuno-analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge Library, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a POC device for the diagnosis of allergic conjunctivitis. In addition, it develops biomarkers for detection of other diseases such as hsTNT/I for myocardial injury and NT-proBNP for cardiac heart failure. It has a license and supply agreement with Toray Industries, Inc. for making and distributing the protein detection chips. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.